HK1148202A1
(en )
2011-09-02
Pharmaceutical solutions, process of preparation and therapeutic uses
IN2014CN02616A
(en )
2015-06-26
HK1140940A1
(en )
2010-10-29
Titration of tapentadol
JO3148B1
(en )
2017-09-20
Notch pathway signaling inhibitor compound
MX2014002159A
(en )
2014-04-25
Pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
MX2012007375A
(en )
2012-07-30
3-keto-n-propargyl-1-aminoindan.
MX356728B
(en )
2018-06-12
Pharmaceutical combination for use in the treatment of diabetes type 2.
MX344473B
(en )
2016-12-16
Semisolid aqueous pharmaceutical composition containing tapentadol.
FR2961756B1
(en )
2014-03-07
SYSTEM FOR PRODUCING AND SUPPLYING HYDROGEN AND SODIUM CHLORATE HAVING SODIUM CHLORIDE ELECTROLYSER FOR PRODUCING SODIUM CHLORATE
MX2011006721A
(en )
2011-09-01
Pharmaceutical formulation of nanonised fenofibrate.
MX2012012978A
(en )
2013-04-03
Method of producing pleurodesis.
UA45831U
(en )
2009-11-25
'ionoacetomalate' medicinal energy-polyionic infusion solution
UA45830U
(en )
2009-11-25
'ionoacetomalate with glucose' medicinal energy-polyionic infusion solution
MX2011011180A
(en )
2012-07-25
Compounds having a physiological effect.
MX2012002952A
(en )
2012-04-02
Therapeutic agent for chronic pain.
UA102444C2
(en )
2013-07-10
Disintoxication infusion solution
UA27723U
(en )
2007-11-12
7-? -hydroxy- ? -(2',4'-dichlorophenoxy)-propyl-8-n-(n'-?-hydroxyethyl)-piperazino-3- methylxanthine revealing hypocholesteremic action
UA105167C2
(en )
2014-04-25
Perindopril calcium salt or solvate thereof
MX2011009844A
(en )
2011-09-29
Pharmaceutical composition comprising aliskiren.
LT2007045A
(en )
2008-12-29
Preparation for wound healing and prevention of bandage adhesion to the wound
UA92278C2
(en )
2010-10-11
Combined infusion peparation
UA103224C2
(en )
2013-09-25
Normal;heading 1;heading 2;heading 3;TABLETS FOR COMBINATION THERAPY
UA53769U
(en )
2010-10-25
Process for the treatment of ammonium sulphate
UA65175U
(en )
2011-11-25
Method of uranostaphyloplasty
MD4291C1
(en )
2015-02-28
Medicinal preparation for the treatment of otitis